Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06008392 | INTERogating Cancer for Etiology, Prevention and Therapy Navigation(INTERCEPTioN) | recruiting | — | 500 | Mayo ClinicOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT06444815 | A Study of VET3-TGI in Patients With Solid Tumors(STEALTH-001) | recruiting | Phase 1 | 60 | KaliVir ImmunotherapeuticsINDUSTRY | 1 | Apr 7, 2026 | clinicaltrials |
| NCT06911827 | A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients | recruiting | Phase 1 / Phase 2 | 149 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 7, 2026 | clinicaltrials |
| NCT05785741 | A Study of DB-1310 in Advanced/Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 1,000 | DualityBio Inc.INDUSTRY | 2 | Apr 6, 2026 | clinicaltrials |
| NCT05873608 | Communication Issues in Patient and Provider Discussions of Immunotherapy | recruiting | N/A | 125 | Emory UniversityOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06306638 | Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction | recruiting | Phase 1 / Phase 2 | 42 | Roswell Park Cancer InstituteOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT06773091 | A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors(NKSOLID) | recruiting | Phase 1 | 76 | Shanghai NK Cell Technology Co., LTDINDUSTRY | 1 | Apr 6, 2026 | clinicaltrials |
| NCT05752552 | Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours | recruiting | Phase 1 | 55 | DeuterOncologyINDUSTRY | 3 | Apr 3, 2026 | clinicaltrials |
| NCT07446153 | A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects | recruiting | Phase 1 / Phase 2 | 282 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 3, 2026 | clinicaltrials |
| NCT07510321 | FL-261 Imaging for Cancer Diagnosis and Staging | recruiting | — | 12 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT04475640 | Cancer Genetic Testing in Ethnic Populations | recruiting | N/A | 1,800 | Mayo ClinicOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT04665206 | Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 434 | Vivace Therapeutics, IncINDUSTRY | 2 | Apr 2, 2026 | clinicaltrials |
| NCT07221409 | Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment | recruiting | N/A | 24 | Mayo ClinicOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT02457962 | Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study | recruiting | — | 15,000 | Mayo ClinicOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05735080 | Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer(INX-315-01) | recruiting | Phase 1 / Phase 2 | 150 | Incyclix BioINDUSTRY | 2 | Apr 1, 2026 | clinicaltrials |
| NCT05773820 | A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 210 | Wigen Biomedicine Technology (Shanghai) Co., Ltd.INDUSTRY | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06915727 | An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors | recruiting | Phase 3 | 20 | Mayo ClinicOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT07505069 | Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors | recruiting | Early Phase 1 | 10 | Nanolattix Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 1, 2026 | clinicaltrials |
| NCT05223608 | Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy(ImmuCCo) | recruiting | N/A | 651 | Centre Oscar LambretOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT06395441 | Wisconsin Ginseng for Decreasing Cancer Related Fatigue | recruiting | Phase 3 | 160 | Mayo ClinicOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT06770569 | A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors | recruiting | Phase 1 | 100 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 2 | Mar 30, 2026 | clinicaltrials |
| NCT06805461 | PumaRx Registry Trial(PumaRx) | recruiting | — | 1,000 | RenovoRxINDUSTRY | 1 | Mar 30, 2026 | clinicaltrials |
| NCT07089927 | Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial | recruiting | N/A | 30 | Mayo ClinicOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT03297606 | Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)(CAPTUR) | recruiting | Phase 2 | 720 | Canadian Cancer Trials GroupNETWORK | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07306338 | Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment | recruiting | — | 10 | University of Southern CaliforniaOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07408375 | Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology(Pulmojet 3) | recruiting | N/A | 560 | Nantes University HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT03667170 | KN035 for dMMR/MSI-H Advanced Solid Tumors | recruiting | Phase 2 | 200 | 3D Medicines (Sichuan) Co., Ltd.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT04891198 | ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors | recruiting | Phase 2 | 126 | 3D Medicines (Sichuan) Co., Ltd.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT05024214 | Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors | recruiting | Phase 1 / Phase 2 | 170 | 3D Medicines (Sichuan) Co., Ltd.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07262164 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors | recruiting | Phase 1 | 30 | Shanghai Virogin Biotech Co., Ltd.INDUSTRY | 1 | Mar 25, 2026 | clinicaltrials |
| NCT07222969 | A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 146 | Vibrant Sciences LimitedINDUSTRY | 2 | Mar 23, 2026 | clinicaltrials |
| NCT07487597 | Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors | recruiting | Early Phase 1 | 24 | TCRCure Biopharma Ltd.INDUSTRY | 1 | Mar 23, 2026 | clinicaltrials |
| NCT07032077 | A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors | recruiting | Phase 2 | 100 | Shandong Suncadia Medicine Co., Ltd.INDUSTRY | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07229638 | A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors | recruiting | Phase 1 / Phase 2 | 70 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Mar 20, 2026 | clinicaltrials |
| NCT00900471 | Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors | recruiting | — | 20,000 | Wake Forest University Health SciencesOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT05306509 | Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology(NiCE) | recruiting | N/A | 120 | Children's Hospital of Fudan UniversityOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT07477886 | Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer | recruiting | — | 134 | Mayo ClinicOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT00571389 | A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. | recruiting | — | 1,500 | BioCytics, Inc.INDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT04443088 | An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors(KEYNOTE-E12) | recruiting | Phase 1 | 78 | Shenzhen Ionova Life Sciences Co., Ltd.INDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT05101070 | S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors(aCCeleR8-001) | recruiting | Phase 1 / Phase 2 | 282 | ShionogiINDUSTRY | 2 | Mar 18, 2026 | clinicaltrials |
| NCT05689853 | Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 87 | AkesoINDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06244771 | A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors(PROSPER) | recruiting | Phase 1 / Phase 2 | 403 | Frontier Medicines CorporationINDUSTRY | 3 | Mar 18, 2026 | clinicaltrials |
| NCT06422455 | Access to Genetic Testing in Underserved Patients With Cancer | recruiting | N/A | 800 | University of Southern CaliforniaOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06804824 | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors | recruiting | Phase 1 | 220 | Vividion Therapeutics, Inc.INDUSTRY | 2 | Mar 18, 2026 | clinicaltrials |
| NCT07479667 | An Antibody-armored Dendritic Cell in Patients With Solid Tumors(dendritic cell) | recruiting | Phase 1 | 8 | Shanghai Cell Therapy Group Co.,LtdINDUSTRY | 1 | Mar 18, 2026 | clinicaltrials |
| NCT04119024 | Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | recruiting | Phase 1 | 18 | Anusha KalbasiOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT05888532 | 64Cu-GRIP B in Patients With Advanced Malignancies | recruiting | Phase 1 / Phase 2 | 91 | Rahul AggarwalOTHER | 1 | Mar 17, 2026 | clinicaltrials |
| NCT05112614 | Role of Gut Microbiome in Cancer Therapy | recruiting | — | 3,000 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT06730204 | Standardized Nutritional Management of Pediatric Patients With Solid Tumors | recruiting | N/A | 400 | Children's Hospital of Fudan UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07475182 | Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers | recruiting | Early Phase 1 | 10 | Hainan Cancer HospitalOTHER | 1 | Mar 16, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Apr 7, 2026source: clinicaltrials